Debate: Treatment of patients with recurrent ovarian cancer should be treated with antiangiogenic agents in combination with chemotherapy

David Boruta, John Farley, Michael J. Birrer, Paul Sabbatini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)12-15
Number of pages4
JournalClinical Ovarian Cancer
Volume2
Issue number1
DOIs
StatePublished - 2009
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this